Opis działalności
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Zarząd & Rada nadzorcza
CEO |
Guillaume Daniellot |
Zarząd |
Dr. Peter Hackel, Camila Finzi, Wolfgang Becker, Jason Forbes , Holger Haderer, Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Rahma Samow, Matthias Schupp, Dr Christian Ullrich |
Rada nadzorcza |
Petra Rumpf, Dr. Beat Lüthi, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol, Regula Wallimann |
Dane firmy
Nazwa: |
Straumann Holding AG |
Adres: |
Peter Merian-Weg 12,CH-4052 Basel |
Telefon: |
+41-61-965-1111 |
Fax: |
+41-61-965-1101 |
E-mail: |
info@straumann.com
|
Internet: |
www.straumann.com |
Przemysł: |
Służba zdrowia |
Sektor: |
Produkty Medyczne |
Podsektor: |
Zaawansowane Urządzenia Medyczne |
Koniec roku finansowego: |
31.12 |
Free float: |
57,90% |
Data IPO: |
01.01.1998 |